Breast cancer risk feedback to women in the UK NHS breast screening population
D. Gareth Evans(Manchester Academic Health Science Centre), Anthony Howell(Breast Cancer Care), Jamie C. Sergeant(Manchester Academic Health Science Centre), Donna Watterson(Wythenshawe Hospital), Jack Cuzick(Queen Mary University of London), Ursula Beetles(Manchester Academic Health Science Centre), David French(UNSW Sydney), Sarah Dawe(Wythenshawe Hospital), Mary Wilson(St Mary's Hospital), Elaine F. Harkness(Manchester Academic Health Science Centre), Michelle Harvie(Manchester Academic Health Science Centre), Paula Stavrinos(Breast Cancer Research Foundation), Adam R. Brentnall(Queen Mary University of London), Louise S. Donnelly(Breast Cancer Research Foundation), Susan Astley(University of Manchester), Iain Buchan(University of Liverpool), Sarah Ingham(Manchester Academic Health Science Centre), Lynne Fox(Breast Cancer Research Foundation)
Cited by 137
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k